TY - JOUR T1 - A logistic model of CoV-2 propagation JF - medRxiv DO - 10.1101/2020.07.20.20157826 SP - 2020.07.20.20157826 AU - Robert F. Weiss Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/26/2020.07.20.20157826.abstract N2 - We describe an elemental logistic model for the propagation of CoV-2 in a community and illustrate the sensitivity of the model to key parameters such as R0, the initial rate of infections per infected person, and A0, the fraction of infected people developing neutralizing antibodies. We demonstrate the importance of the duration of immunity in the population, the development of waves of new cases of infection, and the effect of premature opening of local economies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author has received no funding at any time for any aspect of the submitted work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data presented in the manuscript is available immediately ER -